| Arthur Catsam, MD | |
|
330 Pomfret St, Putnam, CT 06260-1854 | |
| (860) 928-2736 | |
| (860) 928-6367 |
| Full Name | Arthur Catsam |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 330 Pomfret St, Putnam, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700878063 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 031716 (Connecticut) | Primary |
| Entity Name | Prohealth Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720194053 PECOS PAC ID: 1355246950 Enrollment ID: O20031205000602 |
News Archive
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added roller compaction to its solid oral dosage form manufacturing capabilities. The company has purchased two roller compactors, a pilot-scale Vector TFC-220 roller compactor with a rate of 20 kg/hour, and a Vector TFC-LAB Micro lab-scale roller compactor with a rate of 1 kg/hour. Both machines have been integrated into Pharmatek's GMP facility and are ready for GMP manufacturing.
Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.
Adults with low-grade gliomas, a form of brain tumor, who received a chemotherapy regimen following completion of radiation therapy, lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a National Institutes of Health-supported randomized controlled clinical trial.
Farm laborers in yellow safety vests walked through neatly arranged rows of grapes Friday, harvesting the last of the deep purple bundles that hung from the vines, even as the sky behind them was dark with soot.
› Verified 5 days ago
| Entity Name | Day Kimball Healthcare, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649243478 PECOS PAC ID: 5092773549 Enrollment ID: O20041229001007 |
News Archive
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added roller compaction to its solid oral dosage form manufacturing capabilities. The company has purchased two roller compactors, a pilot-scale Vector TFC-220 roller compactor with a rate of 20 kg/hour, and a Vector TFC-LAB Micro lab-scale roller compactor with a rate of 1 kg/hour. Both machines have been integrated into Pharmatek's GMP facility and are ready for GMP manufacturing.
Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.
Adults with low-grade gliomas, a form of brain tumor, who received a chemotherapy regimen following completion of radiation therapy, lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a National Institutes of Health-supported randomized controlled clinical trial.
Farm laborers in yellow safety vests walked through neatly arranged rows of grapes Friday, harvesting the last of the deep purple bundles that hung from the vines, even as the sky behind them was dark with soot.
› Verified 5 days ago
| Entity Name | Day Kimball Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376813972 PECOS PAC ID: 1557514411 Enrollment ID: O20130102000091 |
News Archive
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added roller compaction to its solid oral dosage form manufacturing capabilities. The company has purchased two roller compactors, a pilot-scale Vector TFC-220 roller compactor with a rate of 20 kg/hour, and a Vector TFC-LAB Micro lab-scale roller compactor with a rate of 1 kg/hour. Both machines have been integrated into Pharmatek's GMP facility and are ready for GMP manufacturing.
Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.
Adults with low-grade gliomas, a form of brain tumor, who received a chemotherapy regimen following completion of radiation therapy, lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a National Institutes of Health-supported randomized controlled clinical trial.
Farm laborers in yellow safety vests walked through neatly arranged rows of grapes Friday, harvesting the last of the deep purple bundles that hung from the vines, even as the sky behind them was dark with soot.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arthur Catsam, MD 330 Pomfret Street, Putnam, CT 06260-0926 Ph: (860) 928-2736 | Arthur Catsam, MD 330 Pomfret St, Putnam, CT 06260-1854 Ph: (860) 928-2736 |
News Archive
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added roller compaction to its solid oral dosage form manufacturing capabilities. The company has purchased two roller compactors, a pilot-scale Vector TFC-220 roller compactor with a rate of 20 kg/hour, and a Vector TFC-LAB Micro lab-scale roller compactor with a rate of 1 kg/hour. Both machines have been integrated into Pharmatek's GMP facility and are ready for GMP manufacturing.
Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.
Adults with low-grade gliomas, a form of brain tumor, who received a chemotherapy regimen following completion of radiation therapy, lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a National Institutes of Health-supported randomized controlled clinical trial.
Farm laborers in yellow safety vests walked through neatly arranged rows of grapes Friday, harvesting the last of the deep purple bundles that hung from the vines, even as the sky behind them was dark with soot.
› Verified 5 days ago
Timothy E Cooper, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Pomfret Street, Putnam, CT 06260 Phone: 860-928-2736 Fax: 860-928-6367 | |
Mukti J Patel-prineas, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 Pomfret St, Putnam, CT 06260 Phone: 860-963-7917 Fax: 860-963-0018 | |
Gerald Bland Sullivan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7 Kennedy Dr, Putnam, CT 06260 Phone: 860-928-6541 Fax: 860-928-8268 | |
Dr. Youlan Tang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Pomfret St, Putnam, CT 06260 Phone: 860-928-6541 | |
Charles L Wreschner, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 235 Pomfret St, Putnam, CT 06260 Phone: 860-928-0493 Fax: 860-928-9255 | |
Dr. Dominick F Roto Ii, DO FAAFP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 Pomfret St, Putnam, CT 06260 Phone: 860-928-5248 Fax: 860-928-5286 | |
Dr. Rosemary Ijeoma Maduka, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Pomfret St, Putnam, CT 06260 Phone: 860-928-2736 |